Skip to content
10-Q

Quarterly Report

European Biotech Acquisition Corp.

0001193125-22-221316

← back to feed
Filed
Aug 15, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$560.18K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$347.19K
Cash And Equivalents Q2 2022 · Jun 30, 2022 $308.1K
Cash And Equivalents Q2 2022 · Dec 31, 2021 $868.28K
Stockholders Equity Q2 2022 · Jun 30, 2022 −$5.07M
Stockholders Equity Q2 2022 · Mar 31, 2022 −$5.18M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$6.69M
Stockholders Equity restated Q2 2022 · Jun 30, 2021 −$7.44M
Stockholders Equity restated Q2 2022 · Mar 31, 2021 −$7.36M
Stockholders Equity Q2 2022 · Jan 7, 2021 $0
Current Liabilities Q2 2022 · Jun 30, 2022 $436.51K
Current Liabilities Q2 2022 · Dec 31, 2021 $505.2K
Total Liabilities Q2 2022 · Jun 30, 2022 $5.65M
Total Liabilities Q2 2022 · Dec 31, 2021 $7.61M
Current Assets Q2 2022 · Jun 30, 2022 $483.75K
Current Assets Q2 2022 · Dec 31, 2021 $916.47K
Total Assets Q2 2022 · Jun 30, 2022 $128.23M
Total Assets Q2 2022 · Dec 31, 2021 $128.47M
Sga Expense Q2 2022 · Jun 30, 2022 $312.37K
Sga Expense Q2 2022 · Jun 30, 2022 $515.63K
Sga Expense Q2 2022 · Jun 30, 2021 $134.81K
Sga Expense Q2 2022 · Jun 30, 2021 $224.66K
Net Income Q2 2022 · Jun 30, 2022 $200.69K
Net Income Q2 2022 · Jun 30, 2022 $1.71M
Net Income Q2 2022 · Mar 31, 2022 $1.51M
Net Income Q2 2022 · Jun 30, 2021 $473.52K
Net Income Q2 2022 · Jun 30, 2021 $728.36K
Net Income Q2 2022 · Mar 31, 2021 $254.84K
Operating Income Q2 2022 · Jun 30, 2022 −$372.37K
Operating Income Q2 2022 · Jun 30, 2022 −$635.63K
Operating Income Q2 2022 · Jun 30, 2021 −$194.81K
Operating Income Q2 2022 · Jun 30, 2021 −$304.66K